Cataract Lens Pipeline

New cataract replacement lenses, and how far each one has got: in the lab, in a trial, or approved. Each fact links to its source.

Not medical advice. This page lists facts from public records. It does not tell you which lens to pick, and it does not tell you to wait for a new one. Ask your eye surgeon.

Last updated . 41 lenses and drugs.

How far each one has got

Approved (US)
16
The FDA approved it. A US surgeon can use it.
Approved elsewhere
0
On sale in Europe or other places. Not in the US.
Pivotal trial
3
The large trial that the FDA needs for approval.
Early trial
22
A small first test in people.
Lab
0
No test in people yet.
Lenses and drugs. Select a name to see its facts and sources.
LensStageStatus
Fixed focusMonofocal plus, EDOF (extended depth of focus), multifocal and trifocal lenses. The lens does not move.
AlconApproved (US)Approved
Company
Alcon
Type
EDOF
Where
US now
Codes
DFT015

Summary and trade-offs: not written yet.

Latest

: The FDA approved the lens and its toric models.Regulator

FDA approvals

Sources

Last reviewed 2026-11-21

AlconApproved (US)Approved
Company
Alcon
Type
Trifocal
Where
US now
Codes
CNWTT0, CNATT0

Summary and trade-offs: not written yet.

Latest

: The FDA approved the lens, also preloaded in the AutonoMe injector.Regulator

Trials

  • NCT05796453: Completed470 people · Puerto Rico, United States · start 2023-09-19 · end 2026-08-21
  • NCT07768475: Active, not recruiting266 people · United States · start 2025-07-07 · end 2026-11-12

FDA approvals

Last reviewed 2026-11-21

AlconApproved (US)Approved
Company
Alcon
Type
Trifocal
Where
US now
Codes
PXYWT0

Summary and trade-offs: not written yet.

Latest

: The FDA approved the lens as a small optical change to Clareon PanOptix.Regulator

Trials

  • NCT06400745: Completed87 people · United States · start 2024-06-18 · end 2025-04-30
  • NCT06401551: Completed71 people · United States · start 2024-06-18 · end 2025-04-30
  • NCT07161635: Completed110 people · United States · start 2025-10-14 · end 2026-10-07

FDA approvals

Last reviewed 2026-11-21

AlconApproved (US)Approved
Company
Alcon
Type
EDOF
Where
US now

Summary and trade-offs: not written yet.

Latest

: The FDA approved the lens and its toric model.Regulator

Trials

  • NCT05796453: Completed470 people · Puerto Rico, United States · start 2023-09-19 · end 2026-08-21
  • NCT05852470: Completed155 people · United States · start 2023-05-23 · end 2023-10-27
  • NCT06784063: Completed40 people · United States · start 2025-04-10 · end 2025-06-13

FDA approvals

Last reviewed 2026-11-21

AlconApproved (US)Approved
Company
Alcon
Type
EDOF
Where
US now

Summary and trade-offs: not written yet.

Latest

: The FDA approved the lens and its toric models.Regulator

Trials

  • NCT07484191: Active, not recruiting165 people · Australia · start 2026-04-28 · end 2027-02

FDA approvals

Last reviewed 2026-11-21

LenstecApproved (US)Approved
Company
Lenstec
Type
Multifocal (bifocal)
Where
US now
Codes
SBL-3

Summary and trade-offs: not written yet.

Latest

: The FDA approved the new name, ClearView 3. The old name was SBL-3.Regulator

FDA approvals

Last reviewed 2026-11-21

Bausch & LombApproved (US)Approved
Company
Bausch & Lomb
Type
Multifocal
Where
US now
Codes
EN, EPN

Summary and trade-offs: not written yet.

Latest

: The FDA approved the lens and its toric model.Regulator

FDA approvals

Sources

Last reviewed 2026-11-21

Beaver-Visitec International (BVI)Approved (US)Approved
Company
Beaver-Visitec International (BVI)
Type
Trifocal
Where
US now

Summary and trade-offs: not written yet.

Latest

: The FDA approved the lens.Regulator

Trials

  • NCT04176965: Completed539 people · United States · start 2022-04-28 · end 2024-05-13

FDA approvals

Sources

Last reviewed 2026-11-21

AcuFocusApproved (US)Approved
Company
AcuFocus
Type
EDOF
Where
US now

Summary and trade-offs: not written yet.

Latest

: The FDA approved the lens for one eye only, to give monovision.Regulator

Trials

  • NCT05574270: Completed45 people · Philippines, Singapore · start 2022-07-12 · end 2024-11-28

FDA approvals

Sources

Last reviewed 2026-11-21

RaynerApproved (US)Approved
Company
Rayner
Type
Monofocal plus
Where
US now
Codes
RAO200E, RAO210T

Summary and trade-offs: not written yet.

Latest

: The FDA approved the toric model, RayOne EMV Toric.Regulator

Trials

  • NCT05985304: Completed274 people · United States · start 2023-08-10 · end 2024-10-23

FDA approvals

Last reviewed 2026-11-21

RaynerApproved (US)Approved
Company
Rayner
Type
Multifocal
Where
US now
Codes
RAO605G, RAO615X

Summary and trade-offs: not written yet.

Latest

: The FDA approved the lens and its toric model.Regulator

FDA approvals

Sources

Last reviewed 2026-11-21

Johnson & Johnson Surgical VisionApproved (US)Approved
Company
Johnson & Johnson Surgical Vision
Type
Monofocal plus
Where
US now
Codes
ICB00

Summary and trade-offs: not written yet.

Latest

: The FDA approved the lens and its toric models.Regulator

Trials

  • NCT05025345: Completed228 people · United States · start 2021-09-02 · end 2022-06-17
  • NCT05090813: Completed24 people · China · start 2021-12-24 · end 2024-04-22
  • NCT05396599: Terminated35 people · United States · start 2022-06-30 · end 2023-04-07
  • NCT05481125: Completed203 people · United States · start 2022-10-10 · end 2023-10-16

FDA approvals

Last reviewed 2026-11-21

Johnson & Johnson Surgical VisionApproved (US)Approved
Company
Johnson & Johnson Surgical Vision
Type
Multifocal
Where
US now
Codes
DRN00V

Summary and trade-offs: not written yet.

Latest

: The FDA approved the toric model, TECNIS Odyssey Toric II.Regulator

Trials

  • NCT07768475: Active, not recruiting266 people · United States · start 2025-07-07 · end 2026-11-12

FDA approvals

Last reviewed 2026-11-21

Johnson & Johnson Surgical VisionApproved (US)Approved
Company
Johnson & Johnson Surgical Vision
Type
EDOF
Where
US now
Codes
DEN00V

Summary and trade-offs: not written yet.

Latest

: The FDA approved the lens and its toric models.Regulator

Trials

  • NCT05574959: Terminated243 people · United States · start 2022-10-24 · end 2023-10-24
  • NCT06377514: Completed245 people · United States · start 2024-06-03 · end 2025-04-23

FDA approvals

Last reviewed 2026-11-21

Johnson & Johnson Surgical VisionApproved (US)Approved
Company
Johnson & Johnson Surgical Vision
Type
Multifocal
Where
US now
Codes
ZFR00V

Summary and trade-offs: not written yet.

Latest

: The FDA approved the lens and its toric models.Regulator

Trials

  • NCT05090826: Completed42 people · China · start 2021-12-28 · end 2024-04-30
  • NCT05396599: Terminated35 people · United States · start 2022-06-30 · end 2023-04-07

FDA approvals

Last reviewed 2026-11-21

Carl Zeiss MeditecPivotal trialActive
Company
Carl Zeiss Meditec
Type
Trifocal
Where
Unknown

Summary and trade-offs: not written yet.

Latest

: The US trial finished.Company claim

Trials

  • NCT06264232: Completed284 people · United States · start 2024-07-12 · end 2025-12-01
  • NCT06111222: Completed69 people · Germany, Spain · start 2023-10-31 · end 2026-01-13

Last reviewed 2026-11-21

Bausch & LombPivotal trialActive
Company
Bausch & Lomb
Type
EDOF
Where
Unknown
Codes
EY

Summary and trade-offs: not written yet.

Latest

: The US trial finished.Company claim

Trials

  • NCT06333015: Completed304 people · United States · start 2024-08-07 · end 2026-06-11

Sources

Last reviewed 2026-11-21

SpyGlass PharmaPivotal trialActive
Company
SpyGlass Pharma
Type
Lens that holds a glaucoma drug
Where
Unknown

Summary and trade-offs: not written yet.

Latest

: The first of two US trials (Rhine) started.Company claim

Trials

  • NCT07218783: Recruiting400 people (planned) · United States · start 2025-10-15 · end 2031-03-31
  • NCT07218796: Recruiting400 people (planned) · United States · start 2025-10-28 · end 2031-05-31
  • NCT06120842: Active, not recruiting201 people · United States · start 2023-10-13 · end 2027-11
  • NCT07154797: Completed24 people · Honduras · start 2022-04-21 · end 2022-12-13

Last reviewed 2026-11-21

CristalensEarly trialStalled
Company
Cristalens
Type
Multifocal
Where
Unknown

Summary and trade-offs: not written yet.

Latest

: Last update of the trial records. ClinicalTrials.gov now shows their status as unknown.Company claim

Trials

  • NCT06323915: Unknown84 people (planned) · Spain · start 2021-04-20 · end 2025-09-20
  • NCT06327347: Unknown50 people (planned) · Germany · start 2022-07-17 · end 2026-07-31

Last reviewed 2026-11-21

Carl Zeiss MeditecEarly trialActive
Company
Carl Zeiss Meditec
Type
EDOF
Where
Unknown

Summary and trade-offs: not written yet.

Latest

: The trial in four European countries finished.Company claim

Trials

  • NCT07092020: Completed220 people · Bulgaria, Czechia, Romania, Spain · start 2025-10-01 · end 2026-07-27

Sources

Last reviewed 2026-11-21

Johnson & Johnson Surgical VisionEarly trialActive
Company
Johnson & Johnson Surgical Vision
Type
Not stated in the sources
Where
Unknown
Codes
C0001, C0002

Summary and trade-offs: not written yet.

Latest

: The second small trial in France finished.Company claim

Trials

  • NCT05036070: Completed113 people · France · start 2021-11-18 · end 2024-04-24
  • NCT05531292: Completed106 people · France · start 2022-11-22 · end 2025-05-20

Last reviewed 2026-11-21

Cutting EdgeEarly trialActive
Company
Cutting Edge
Type
Trifocal
Where
Unknown

Summary and trade-offs: not written yet.

Latest

: The trial in Czechia and Spain finished.Company claim

Trials

  • NCT04465344: Completed188 people · Czechia, Spain · start 2021-05-31 · end 2024-06-27

Sources

Last reviewed 2026-11-21

Teleon SurgicalEarly trialActive
Company
Teleon Surgical
Type
Bifocal, for late macular degeneration
Where
Unknown

Summary and trade-offs: not written yet.

Latest

: A trial was registered. It is planned to start in 2027.Company claim

Trials

  • NCT07915076: Not yet recruiting35 people (planned) · start 2027-02-01 · end 2030-08-01

Sources

Last reviewed 2026-11-21

AlconEarly trialActive
Company
Alcon
Type
Trifocal
Where
Unknown
Codes
LPYWT0

Summary and trade-offs: not written yet.

Latest

: The trial started in Australia, India and the Philippines.Company claim

Trials

  • NCT07587138: Recruiting66 people (planned) · Australia, India, Philippines · start 2026-10-09 · end 2027-07

Sources

Last reviewed 2026-11-21

Cutting EdgeEarly trialActive
Company
Cutting Edge
Type
Monofocal plus
Where
Unknown

Summary and trade-offs: not written yet.

Latest

: The trial in France started.Company claim

Trials

  • NCT06258707: Recruiting58 people (planned) · France · start 2024-10-14 · end 2028-06-15

Sources

Last reviewed 2026-11-21

Cutting EdgeEarly trialActive
Company
Cutting Edge
Type
Multifocal
Where
Unknown

Summary and trade-offs: not written yet.

Latest

: The trial in France started.Company claim

Trials

  • NCT06446817: Recruiting57 people (planned) · France · start 2024-12-19 · end 2028-12

Sources

Last reviewed 2026-11-21

Cutting EdgeEarly trialStalled
Company
Cutting Edge
Type
Monofocal plus
Where
Unknown

Summary and trade-offs: not written yet.

Latest

: Last update of the trial record. It still says active, after its planned end in April 2025.Company claim

Trials

  • NCT06105190: Active, not recruiting251 people · Austria, Czechia, Germany, Philippines, Singapore, Spain · start 2023-06-21 · end 2025-04

Sources

Last reviewed 2026-11-21

Omega OphthalmicsEarly trialStalled
Company
Omega Ophthalmics
Type
Lens holder (capsule)
Where
Unknown
Codes
Model VI

Summary and trade-offs: not written yet.

Latest

: Last update of the trial record. ClinicalTrials.gov now shows its status as unknown.Company claim

Trials

  • NCT04574115: Unknown30 people · Costa Rica · start 2021-02-06 · end 2024-06

Sources

Last reviewed 2026-11-21

VisionCareEarly trialStalled
Company
VisionCare
Type
Implantable telescope for late macular degeneration
Where
Unknown

Summary and trade-offs: not written yet.

Latest

: Last update of the trial record. It still says recruiting, after its planned end in December 2025.Company claim

Trials

  • NCT05438732: Recruiting125 people (planned) · United States · start 2022-06-16 · end 2025-12

Sources

Last reviewed 2026-11-21

Johnson & Johnson Surgical VisionEarly trialActive
Company
Johnson & Johnson Surgical Vision
Type
Not stated in the sources
Where
Unknown
Codes
C1V000, C2V000

Summary and trade-offs: not written yet.

Latest

: The trial in Australia and New Zealand finished.Company claim

Trials

  • NCT04890249: Completed221 people · Australia, New Zealand · start 2021-06-23 · end 2023-01-31

Sources

Last reviewed 2026-11-21

Z OpticsEarly trialActive
Company
Z Optics
Type
EDOF
Where
Unknown
Codes
FG-80030.1

Summary and trade-offs: not written yet.

Latest

: The trial started in Portugal, Spain and Switzerland.Company claim

Trials

  • NCT05955846: Recruiting60 people (planned) · Portugal, Spain, Switzerland · start 2025-08-07 · end 2027-09

Sources

Last reviewed 2026-11-21

Changes focusAccommodating lenses (they change shape like a young eye) and adjustable lenses (the doctor tunes them after surgery).
RxSightApproved (US)Approved
Company
RxSight
Type
Adjustable
Where
US now
Codes
LAL, LAL+

Summary and trade-offs: not written yet.

Latest

: The FDA approved LAL+, a model with a changed optical design.Regulator

Trials

  • NCT05202808: Completed500 people · United States · start 2021-12-03 · end 2024-12-16

FDA approvals

Last reviewed 2026-11-21

AlconEarly trialDiscontinued
Company
Alcon
Type
Accommodating
Where
Unknown
Codes
AAL-FAIOL

Summary and trade-offs: not written yet.

Latest

: Alcon stopped the trial. The record gives the reason as a management decision.Company claim

Trials

  • NCT07147192: Terminated17 people · Costa Rica, Dominican Republic, El Salvador, Panama · start 2025-12-03 · end 2026-10-22

Sources

Last reviewed 2026-11-21

AdaptilensEarly trialActive
Company
Adaptilens
Type
Accommodating
Where
Unknown

Summary and trade-offs: not written yet.

Latest

: The trial was registered. It has not started yet.Company claim

Trials

  • NCT07607860: Not yet recruiting100 people (planned) · start 2026-09 · end 2030-12

Sources

Last reviewed 2026-11-21

AlconEarly trialActive
Company
Alcon
Type
Accommodating
Where
Unknown
Codes
BAL-FAIOL

Summary and trade-offs: not written yet.

Latest

: The trial record says the trial is active and takes no new people.Company claim

Trials

  • NCT05317728: Active, not recruiting175 people · Costa Rica, Dominican Republic, Mexico, Panama · start 2023-03-31 · end 2026-11

Sources

Last reviewed 2026-11-21

LensGenEarly trialStalled
Company
LensGen
Type
Accommodating
Where
Unknown

Summary and trade-offs: not written yet.

Latest

: Last update of the trial record. It still says the trial has not started.Company claim

Trials

  • NCT05364983: Not yet recruiting56 people (planned) · start 2023-05 · end 2026-11

Sources

Last reviewed 2026-11-21

FSV6Early trialStalled
Company
FSV6
Type
Accommodating
Where
Unknown

Summary and trade-offs: not written yet.

Latest

: Last update of the trial record. ClinicalTrials.gov now shows its status as unknown.Company claim

Trials

  • NCT04756908: Unknown200 people (planned) · Costa Rica, Mexico · start 2020-10-08 · end 2024-06

Sources

Last reviewed 2026-11-21

Perfect LensEarly trialActive
Company
Perfect Lens
Type
Laser adjustment of an implanted lens
Where
Unknown

Summary and trade-offs: not written yet.

Latest

: The trial in Czechia finished.Company claim

Trials

  • NCT07384182: Completed19 people · Czechia · start 2023-10-15 · end 2024-11-12

Sources

Last reviewed 2026-11-21

No surgeryDrugs that try to slow or clear a cataract.The FDA has not approved any drug or eye drop to treat a cataract.
Nacuity PharmaceuticalsEarly trialActive
Company
Nacuity Pharmaceuticals
Type
Drug implant to slow cataract growth
Where
Unknown
Codes
NPI-002

Summary and trade-offs: not written yet.

Latest

: The trial in Australia finished.Company claim

Trials

  • NCT05026632: Completed24 people · Australia · start 2022-01-27 · end 2026-09-03

Sources

Last reviewed 2026-11-21

University of AnbarEarly trialStalled
Company
University of Anbar
Type
Eye drops
Where
Unknown

Summary and trade-offs: not written yet.

Latest

: Last update of the trial record. It still says active, after its planned end in December 2024.Company claim

Trials

  • NCT06639711: Active, not recruiting50 people · Iraq · start 2023-07-10 · end 2024-12-20

Sources

Last reviewed 2026-11-21

Ocusun Ophthalmic PharmaceuticalEarly trialActive
Company
Ocusun Ophthalmic Pharmaceutical
Type
Eye drug for cataract, used twice a day
Where
Unknown
Codes
ZOC2017217

Summary and trade-offs: not written yet.

Latest

: A small pilot trial in the US started.Company claim

Trials

  • NCT07395986: Active, not recruiting8 people · United States · start 2026-02-10 · end 2027-02

Sources

Last reviewed 2026-11-21

Status words

Stalled:
The trial record is out of date and the company is silent.

Words on this page

IOL:
Intraocular lens: the plastic lens a surgeon puts in the eye after the cloudy lens comes out.
EDOF:
Extended depth of focus.
Toric:
A toric lens fixes astigmatism.
PMA:
Premarket approval: the FDA path for these lenses.